Aziyo Biologics Inc. (NASDAQ: AZYO) stock closed at 1.47 per share at the end of the most recent trading day (a 5% change compared to the prior day closing price) with a volume of 839.77K shares and market capitalization of 23.70M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 163 people. Aziyo Biologics Inc. CEO is Ronald K. Lloyd.

The one-year performance of Aziyo Biologics Inc. stock is -71.94%, while year-to-date (YTD) performance is -65.41%. AZYO stock has a five-year performance of %. Its 52-week range is between 1.1 and 9.01, which gives AZYO stock a 52-week price range ratio of 4.68%

Aziyo Biologics Inc. currently has a PE ratio of -1.40, a price-to-book (PB) ratio of 13.34, a price-to-sale (PS) ratio of 1.23, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -60.40%, a ROC of -107.60% and a ROE of 2 588.31%. The company’s profit margin is -75.18%, its EBITDA margin is -58.50%, and its revenue ttm is $36.52 Million , which makes it $3.09 revenue per share.

Of the last four earnings reports from Aziyo Biologics Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Aziyo Biologics Inc.’s next earnings report date is 08th May 2023.

The consensus rating of Wall Street analysts for Aziyo Biologics Inc. is Strong Buy (1), with a target price of $11.38, which is +674.15% compared to the current price. The earnings rating for Aziyo Biologics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aziyo Biologics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aziyo Biologics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 27.94, ATR14 : 0.46, CCI20 : -131.64, Chaikin Money Flow : -0.26, MACD : -0.74, Money Flow Index : 52.07, ROC : -67.33, RSI : 22.03, STOCH (14,3) : 10.57, STOCH RSI : 0.19, UO : 25.94, Williams %R : -89.43), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aziyo Biologics Inc. in the last 12-months were: Brigid A. Makes (Buy at a value of $7 300), David Colpman (Buy at a value of $12 082), Jerome Riebman (Option Excercise at a value of $0), Matthew B. Ferguson (Buy at a value of $126 400), Matthew B. Ferguson (Option Excercise at a value of $0), Peter G. Edwards (Option Excercise at a value of $0), Thomas Englese (Option Excercise at a value of $0), Thomas Englese (Sold 289 shares of value $1 243 )